🧬 HER2: a key biomarker in oncology research
Human Epidermal Growth Factor Receptor 2 (HER2) is one of the most extensively studied biomarkers in oncology. Its expression is widely investigated in preclinical models to better understand tumor biology and evaluate the efficacy of emerging anti-cancer therapies.
The image below illustrates HER2 immunohistochemical staining performed by our histology team using the Ventana platform, demonstrating the high level of expertise, precision and standardization required to generate robust and reproducible data.
At Atlantic Bone Screen, we support preclinical oncology research through high-quality histology services, from tissue processing and immunohistochemistry to whole-slide digital imaging and quantitative image analysis.
By providing reliable tissue characterization and biomarker evaluation, we help our clients better understand treatment effects, investigate mechanisms of action and generate the data needed to advance innovative cancer therapies.
🌍 Proud to support oncology research programs worldwide and contribute to the development of tomorrow’s cancer treatments.
#Oncology #CancerResearch #HER2 #Histology #Immunohistochemistry #IHC #Biomarkers #DrugDevelopment #PreclinicalResearch #Ventana